Carnegie acted as sole global co-ordinator and sole bookrunner in the initial public offering of Q-linea on Nasdaq Stockholm. Q-linea is a diagnostic company focused on developing and delivering solutions for healthcare providers, enabling them to accurately diagnose and treat infectious diseases in the shortest possible time. December 2018.
Healthcare
Initial public offering of Q-linea AB (SE) on Nasdaq Stockholm — SEK 550 million
December 2018